![Wei Chang Zhou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wei Chang Zhou
Director/Miembro de la Junta en WUXI BIOLOGICS (CAYMAN) INC. .
Fortuna: 714 532 $ al 30/06/2024
Cargos activos de Wei Chang Zhou
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
WUXI BIOLOGICS (CAYMAN) INC. | Director/Miembro de la Junta | 01/05/2016 | - |
Director Técnico/Científico/I+D | 01/11/2016 | 31/03/2024 | |
WUXI XDC CAYMAN INC. | Director/Miembro de la Junta | 01/12/2020 | - |
Historial de carrera de Wei Chang Zhou
Antiguos cargos conocidos de Wei Chang Zhou.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | 01/03/2008 | 01/12/2012 |
PDL BIOPHARMA, INC. | Director/Miembro de la Junta | 01/10/2002 | 01/02/2008 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/05/1994 | 01/10/2002 |
Formación de Wei Chang Zhou.
Jiangxi University of Science & Technology | Undergraduate Degree |
University of Hannover | Doctorate Degree |
Estadísticas
Internacional
China | 4 |
Estados Unidos | 4 |
Alemania | 2 |
Operativa
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
WUXI XDC CAYMAN INC. | Commercial Services |
Empresas privadas | 2 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
PDL BioPharma, Inc.
![]() PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Bolsa de valores
- Insiders
- Wei Chang Zhou
- Experiencia